News
9h
Fintel on MSNOppenheimer Initiates Coverage of MBX Biosciences (MBX) with Outperform RecommendationFintel reports that on July 16, 2025, Oppenheimer initiated coverage of MBX Biosciences (NasdaqGS:MBX) with a Outperform recommendation. Analyst Price Forecast Suggests 207.65% Upside As of June 20, ...
Abbott Laboratories remains a top pick in volatile markets thanks to strong fundamentals and regulatory tailwinds.
Oppenheimer analyst Brian Schwartz issued a bullish outlook for Microsoft (NASDAQ: MSFT), raising its price target to $600—a ...
7d
Fintel on MSNOppenheimer Upgrades BridgeBio Pharma (BBIO)Fintel reports that on July 9, 2025, Oppenheimer upgraded their outlook for BridgeBio Pharma (NasdaqGS:BBIO) from Perform to ...
Detailed price information for Sei Investments Company (SEIC-Q) from The Globe and Mail including charting and trades.
CME Group is growing new products, markets, and users, as well as having achieved profit margins beating its sector and key ...
Barclays analyst Benjamin Budish maintained a Hold rating on CME Group today and set a price target of $283.00. The company’s shares closed yesterday at $275.82. Don’t Miss Ti ...
CHICAGO and LONDON, June 30, 2025 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today announced that it will launch CME FX Tape+ to provide centralized reference prices ...
CME FX Tape+ will disseminate reference data at 250 millisecond intervals via websocket API and historic market data files, improving the ability of market participants to confidently analyze the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results